
Mabwell Releases 6 Study Results Of Innovative Drugs And Platforms At The 2025 AACR Annual Meeting
(MENAFN- PR Newswire) SHANGHAI, April 30, 2025 /PRNewswire/ -- Mabwell (688062), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in poster format at the American …